1. Olefir, Yu.V., Romanov, B.K., Kukes, V.G., et al., The role of oxidative stress in the pathogenesis of socially significant human diseases and ways of its drug correction, Med. Vestn. Sev. Kavk., 2021, vol. 16, no. 4, pp. 450–455.
2. Vetsheva, M.S., Sviridov, S.V., and Podkorytova, O.L., Antioxidant therapy in various diseases. Preventing opportunities (literature review), Kremlevsk. Med. Klin. Vestn., 2022, no. 1, pp. 71–77.
3. Fadeeva, N.I., Balabolkin, M.I., Mamaeva, G.G., Kravchenko, T.V., Mishchenko, B.P., and Knyazeva, A.P., Use of nicotinamide and other antioxidant drugs in the complex therapy of type 2 diabetes mellitus, Sakh. Diabet, 2001, no. 1, pp. 21–23.
4. Ludan, V.V., Gorbunov, A.A., and Kasaeva, G.R., The role of antioxidants in the treatment of diabetes mellitus, E-Scio, 2020, no. 12 (51), pp. 665–669.
5. Oblong, J.E., The evolving role of the NAD+/nicotinamide metabolome in skin homeostasis, cellular bioenergetics, and aging, DNA Repair, 2014, vol. 23, pp. 59–63.